The Vatika Group, a leading player in the real estate and hospitality business, has decided to exit its healthcare business- Vatika Medicare.
It was only in January 2015 that the group had announced its foray into healthcare. The group began its operations in Delhi-NCR by acquiring two diagnostic labs ‘Health Square’ from Spry Hospitality for Rs 30 crore. Vatika Medicare, which is one of the verticals of Vatika Hotels, had plans of investing Rs 200 crore to open 15 diagnostic centres in tier II cities, beginning with Delhi-NCR. However, the group did not go ahead with rolling out more diagnostic centres.
The group has already exited its diagnostic centre in Gurgaon around 10 months back. The centre was acquired by a group of four doctors. Its second centre, located in Hauz Khas in Delhi, is likely to be acquired by another group of doctors.
Confirming the news, Deepak Uppal, Director, Vatika Medicare, said, “Yes, we are exiting our healthcare vertical by 31st of this month. We have decided to focus on our core business, which is real estate and hotels.”
HealthCare atHOME (HCAH), a joint-venture between the Burman family (promoters of Dabur) and founders of Health Care At Home, UK, has completed acquisition of Health Impetus Pvt. Ltd., a disease management company involved in providing innovative solutions for the pharma companies to engage patients and doctors. With this new portfolio of services HCAH will now be a “one stop solution” for every segment of the healthcare delivery channel especially pharma sector.
This acquisition marks HCAH’s entry into “Disease management services” thereby becoming an “integrated care management company” which is focused on making a real difference to patient care, outcomes and cost of treatment. HCAH will provide an array of services which include: Disease awareness and diagnostics, patient support and awareness programs, management of diseases through compliance programs, drug delivery and administration, Data analysis and outcome standardization.
The integration besides offering a bouquet of services for disease management will also roll out a range of patient care services like EMI schemes for chronic ailments like Cancer, Diabetes, Hepatitis B etc which will help patients to continue the treatment and meet the high cost of medications.
Commenting on the acquisition, Vivek Srivastava, Co-founder and Chief Executive Officer at Health Care at Home Pvt. Ltd., said, “At HealthCare atHOME India, it is our endeavor to put in place a holistic system of quality health-care which is easily accessible at the patient’s doorstep. With this acquisition, HCAH has increased its bouquet of services to pharma companies. HCAH brings superior clinical skills and Direct to Patient pharmacy delivery skills thus becoming a One Stop Solution to the pharma companies in the patient journey”